Clinical trial
Efficacy and Safety of TF002 in Cutaneous Mastocytosis
NCT00457288 · JADO Technologies GmbH, Industry · Completed
Key facts
| NCT number | NCT00457288 |
|---|---|
| Title | Efficacy and Safety of TF002 in Cutaneous Mastocytosis |
| Official title | Efficacy and Safety of TF002 in Cutaneous Mastocytosis |
| Lead sponsor | JADO Technologies GmbH, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cutaneous Mastocytosis |
| Intervention type | Drug |
| Interventions | TF 002 |
| Enrollment | 30 |
| Start date | Apr 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Apr 6, 2007 |
| Last update posted | Nov 12, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: